Opioids During Pregnancy May Not Raise Psychiatric Risks for Offspring
By Dennis Thompson HealthDay Reporter
THURSDAY, April 24, 2024 -- Prescription opioids taken during pregnancy are not associated with a substantial increase in risk of developmental disorders like ADHD in children, a new study has found.
“A slightly increased risk of neuropsychiatric disorders was found, but this should not be considered clinically meaningful” because it was limited to mothers taking more than one opioid, prescribed high doses and using the drugs over longer periods of time, concluded the research team led by Dong Keon Yon, a professor of pediatrics with Kyung Hee University College of Medicine in Seoul, South Korea.
About 7% of women in the United States are prescribed opioids during pregnancy, according to the U.S. Centers for Disease Control and Prevention.
Previous studies have had mixed findings regarding opioid use during pregnancy and various health outcomes in children, mainly due to small sample sizes and short follow-up periods.
To produce a high-powered examination of the potential problem, researchers analyzed health data for more than 3.1 million infants born in South Korea between 2010 and 2017 to nearly 2.3 million mothers.
Moms were grouped according to the dose, duration and frequency of opioid prescriptions during their pregnancy, and babies were followed an average of six years after birth.
About 7% of infants were exposed to opioids during pregnancy, researchers found.
The team found a small, but clinically insignificant, increased risk for developmental disorders among babies exposed to opioids in the womb.
Exposure to prescription opioids during the first trimester, at higher doses, and for two or more months was associated with a slightly increased risk of mood disorders, ADHD and intellectual disability, researchers said.
However, they also found no significant association when comparing kids exposed to opioids with siblings who weren’t, results show.
The findings were published April 24 in the BMJ.
“These results support cautious opioid prescribing for relief of pain during pregnancy, highlighting the importance of further research for more definitive guidelines,” the team said in a journal news release.
More research is needed, given that opioids are valuable for managing severe pain in some expecting moms, researchers concluded.
Sources
- BMJ, news release, April 24, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Day Care Pick-Up Often Involves Sugary Snacks, Study Finds
THURSDAY, May 2, 2024 -- Giving your kid a drink, snack or small bag of fast food on the way home from day care might distract them during a busy commute, but it’s not doing...
Economy, Election Spur Rising Anxiety Among Americans in 2024
THURSDAY, May 2, 2024 -- A looming presidential election, continued economic struggles and the threat of gun violence have a rising number of Americans more anxious this year...
How Anger Could Raise Your Heart Risks
WEDNESDAY, May 1, 2024 -- Feeling angry constricts blood vessels in unhealthy ways and could raise a person's long-term odds for heart disease, new research warns. “If...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
